Stock LIGAND PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Ligand Pharmaceuticals Inc. OTC Bulletin Board

Equities

US53220K1815

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Ligand Pharmaceuticals Inc.
Jun. 18 Merck Receives FDA Approval for Capvaxive, Triggers $2 Million Payment for Ligand Pharmaceuticals MT
Jun. 18 Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE? (Pneumococcal 21-valent Conjugate Vaccine) for Adults CI

Chart calendar Ligand Pharmaceuticals Inc.

ad6b37b65619108f5780fe49f2483a._QDRvepWY1tdVGBrBQxBZvRFHavpNpVVqEfKfc9PSBY.l2Sn7qxmPCEyZBMDV0Z4N5oJZcKDX8ptkBOTDIQpGGSVZqX2ugMNHhYYFw~662e92a3b6e57d340bb773a51be682eb

Upcoming events on Ligand Pharmaceuticals Inc.

2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-04 Q3 2024 Earnings Release (Projected)
2025-02-05 Q4 2024 Earnings Release (Projected)
2025-04-30 Q1 2025 Earnings Release (Projected)

Past events on Ligand Pharmaceuticals Inc.

2024-06-14 11:30 am Annual General Meeting
2024-06-12 04:00 pm Goldman Sachs Global Healthcare Conference
2024-05-28 Craig Hallum Institutional Investor Conference
2024-05-20 Benchmark Healthcare House Virtual Conference
2024-05-07 04:30 pm Q1 2024 Earnings Call
2024-05-07 04:00 pm Q1 2024 Earnings Release
2024-03-14 10:45 am Barclays Global Healthcare Conference
2024-02-27 08:30 am Q4 2023 Earnings Call
2024-02-27 07:00 am Q4 2023 Earnings Release
2023-12-12 10:30 am Investor and Analyst Day
2023-11-08 04:30 pm Q3 2023 Earnings Call
2023-11-08 04:01 pm Q3 2023 Earnings Release
2023-09-12 12:00 am H.C. Wainwright 25th Annual Global Investment Conference
2023-08-08 04:30 pm Q2 2023 Earnings Call
2023-08-08 04:01 pm Q2 2023 Earnings Release
2023-06-09 11:30 am Annual General Meeting
2023-05-04 04:30 pm Q1 2023 Earnings Call
2023-05-04 04:01 pm Q1 2023 Earnings Release
2023-02-22 04:30 pm FY 2022 Earnings Call
2023-02-22 04:01 pm FY 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		120
118
1.54%		186
173
7.72%		277
270
2.73%		196
184
6.55%		131
129
1.88%
138

EBITDA
Million USD		Released
Forecast
Spread 		62,5
71,8
-12.92%		80,0
76,0
5.23%		165
157
5.05%		87,8
92,7
-5.33%		70,3
84,3
-16.62%
96,1

EBIT
Million USD		Released
Forecast
Spread 		-5,72
7,73
-174.02%		25,8
29,9
-13.58%		78,9
65,7
20.04%		3,04
-6,02
150.48%		11,9
10,7
11.81%
24,8

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		797
797
-0.08%		-10,5
-5,29
-99.33%		47,3
65,2
-27.46%		36,0
-16,9
313.18%		63,7
42,3
50.39%
122

Net income
Million USD		Released
Forecast
Spread 		629
636
-1.03%		-2,99
-2,46
-21.36%		57,6
71,9
-19.9%		-33,4
-12,9
-158.89%		52,2
32,0
62.92%
92,7

EPS
USD		Released
Forecast
Spread 		31,9
32,9
-3.05%		-0,18
-0,13
-44%		3,34
4,25
-21.37%		-1,98
-0,62
-221.95%		2,94
1,91
54.2%
5,00

Announcement Date06/02/2003/02/2117/02/2222/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		45,7
34,2
33.56%		57,4
37,7
52.16%		66,1
38,3
72.41%		50,4
39,6
27.12%		44,0
33,5
31.1%		26,4
25,7
2.46%		32,9
27,2
20.73%		28,1
25,6
9.58%		31,0
27,9
10.94%
32,0


35,3


39,7


26,9


34,4

EBITDA
Million USD		Released
Forecast
Spread 		11,5
11,2
2.5%		22,3
4,58
386.92%		25,0
12,0
108.22%		16,1
29,0
-44.58%		28,2
27,4
2.99%		14,7
17,3
-14.81%		15,0
16,0
-6.3%		10,7
14,2
-25.02%		21,8
16,3
33.77%
21,3


25,0


28,3


15,2


23,5

EBIT
Million USD		Released
Forecast
Spread 		-9,31
-12,2
23.96%		-0,47
-21,4
97.81%		0,64
-12,1
105.24%		-20,1
3,14
-739.35%		14,2
0,28
4968.69%		-1,98
-1,29
-53.6%		-0,12
-1,97
93.79%		-3,36
-3,21
-4.55%		2,99
-1,51
297.71%
4,10


7,36


10,3


-1,11


7,14

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-20,1
-15,1
-33.55%		-0,64
-16,9
96.24%		0,86
-10,2
108.4%		24,1
3,03
696.61%		55,5
1,17
4632.51%		3,17
3,29
-3.54%		-15,3
-2,26
-580.26%		17,1
-1,71
1102.17%		113
3,04
3626.29%
8,66


11,7


14,9


-0,52


7,74

Net income
Million USD		Released
Forecast
Spread 		-15,4
-11,8
-30.89%		-0,90
-13,0
93.11%		0,40
-8,44
104.79%		-17,5
2,71
-746.08%		41,9
-1,49
2912.22%		2,29
1,80
26.94%		-12,8
-3,72
-243.96%		18,2
-1,16
1666.92%		86,1
2,36
3549.18%
6,68


8,97


11,4


-0,40


5,88

EPS
USD		Released
Forecast
Spread 		-0,91
-0,58
-57.99%		-0,05
-0,62
91.9%		0,02
-0,48
104.19%		-1,04
0,32
-430.16%		2,33
0,18
1194.44%		0,13
-0,05
388.89%		-0,74
0,05
-1685.6%		1,03
0,07
1371.43%		4,75
0,23
1995.56%
0,43


0,58


0,68







Announcement Date04/05/2208/08/2207/11/2222/02/2304/05/2308/08/2308/11/2327/02/2407/05/24-----

Upcoming sector events for Ligand Pharmaceuticals Inc.

2024-07-03 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
2024-07-10 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
2024-07-15 CAMURUS AB: Q2 2024 Earnings Release
2024-07-16 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-17 06:45 am JOHNSON & JOHNSON: Q2 2024 Earnings Release
2024-07-17 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-18 01:00 am NOVARTIS AG: Q2 2024 Earnings Release
2024-07-21 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-21 ALMIRALL, S.A.: Q2 2024 Earnings Release
2024-07-22 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Ligand Pharmaceuticals Inc.

2024-06-21 11:28 am DEVA HOLDING: Q1 2024 Earnings Release
2024-06-13 05:21 pm EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
2024-06-11 01:30 am BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
2024-06-07 06:33 am SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
2024-06-07 05:17 am LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
2024-05-30 08:08 am SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-30 07:00 am ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
2024-05-30 02:24 am MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-29 08:00 am FDC LIMITED: Q4 2024 Earnings Release
2024-05-29 05:26 am JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. LGND Stock
  4. Stock
  5. Calendar Ligand Pharmaceuticals Inc.